| FRI, APR 17, 2020 | | | Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
Even as the coronavirus outbreak shows signs of slowing in the United States, local and state governments are extending their shutdown of nonessential businesses into May as officials grapple with how to reopen parts of the economy safely. Meanwhile, medical device firm Abbott Labs told investors this week it's on track this month to ship 4 million of its coronavirus testing kits and will ramp up production as President Donald Trump pushes for some businesses to open as early as May 1. Plus, stocks surged on the news of Gilead's drug showing some effectiveness in treating the coronavirus, giving investors some hope. More on the outbreak below.
This week, we kicked off our first installment of our new weekly digital series - Healthy Returns: The Path Forward, where Meg Tirrell interviews health care leaders who are changing the game tackling Covid-19. Watch her interview with Mike Osterholm, University of Minnesota's director of Center for Infectious Disease Research and Policy. You can also check out the latest speakers joining us for our virtual summit on May 12, and request a complimentary ticket.
| Doctors worry the coronavirus is keeping patients away from hospitals: 'Heart attacks don't stop' | Hospitals across the country have seen a substantial drop in non-coronavirus patients since the outbreak began to spread rapidly across the country, according to the American Hospital Association. Dr. Rod Hochman, CEO of Providence St. Joseph Health in the Seattle area, said he's concerned patients are skipping necessary treatments because they're afraid of catching Covid-19 in the hospitals. Doctors are worried that patients with severe illnesses may suffer permanent damage by avoiding the ER. "The big question is are we going to see a lot more people that have bad outcomes from heart disease, from stroke, from cancer because they've put off what they should have had done but were too afraid to come to the hospital," Hochman said. - Will Feuer | @WillFOIA | | One Medical helping employers map the road back from WFH | Primary care provider One Medical's business model is all about combining digital health and in-person care for its members. Last week, I spoke with CEO Amir Rubin about how that combination has helped its members gain faster access to Covid testing and medical care. He also talked about how they're helping their 6,000 employer clients to devise protocols to bring workers safely back to businesses that have been closed. It's a complicated process on that is going to involve much more testing on a regular basis, as part of the way we'll work now. - Bertha Coombs | @berthacoombs | | Dispatches from Iceland: US response to Covid-19 is 'sad' | Dr. Kari Stefansson, founder of the legendary Icelandic genetics company deCODE, isn't one to mince words. And when we asked him on CNBC's Closing Bell this week about whether the U.S., at 1,000 times Iceland's population, could emulate the island nation's public health response to containing Covid-19, he was true to form: "It would be even easier in a country of your size and your resources," he told us. "You taught us how to do this, but you haven't been doing it yourself, and that is pretty sad." - Meg Tirrell | @megtirrell | | US clinical trials of hydroxychloroquine could show in weeks whether it works | Researchers are working as quickly as science will allow to determine whether hydroxychloroquine, a decades-old malaria drug touted by President Donald Trump as a potential "game changer" in curtailing the Covid-19 pandemic, is effective in fighting the coronavirus. One study at NYU Langone and the University of Washington is a randomized controlled trial designed to determine whether hydroxychloroquine is any better than a placebo in preventing Covid-19. The New York State Department of Health, in partnership with the University of Albany, is also conducting a so-called observational study that researchers hope can shed some insight into the drug's potential effectiveness in a matter of weeks, possibly before May. - Berkeley Lovelace Jr. | @BerkeleyJr | | New Jersey AG opens probe of nursing home deaths | New Jersey has opened an investigation into nursing home deaths across the state after officials discovered 17 bodies piled into a makeshift morgue and more than 100 residents infected with Covid-19 at a long-term care facility, state officials said Thursday. Gov. Phil Murphy said he was "outraged" that staff at the Andover Subacute and Rehabilitation Center in Northern New Jersey piled deceased residents into a small room at the facility. Officials have since discovered that 103 residents have tested positive for the coronavirus and 133 more have flu-like symptoms between the facility's two buildings. The state has ordered 20 refrigerated trucks to serve as temporary mortuaries a few weeks ago and has set up an additional location in central New Jersey that will serve as "temporary storage" for the deceased. - Noah Higgins-Dunn | @higginsdunn - Will Feuer | @WillFOIA - Dawn Kopecki | @Dawn_Kopecki | | Medical advisors for the movie 'Contagion' saw a pandemic coming, but got one big thing wrong | The movie "Contagion" is seeing a surge in popularity as people look for explanations about what's happening in the world today. It's also shockingly accurate as it takes us through a pandemic caused by a highly contagious virus, which bears some similarities with Covid-19. CNBC tracked down a few of the scientists who consulted on the film, and asked them what they would have done differently with the benefit of hindsight. They told us the one thing they didn't expect is that medical workers would be running out of personal protective equipment (PPE) in just a few months. - Chrissy Farr | @chrissyfarr | | WHO 'regrets' Trump's decision to withhold funding, says focus is on saving | The World Health Organization is turning to other countries to help fill any gaps in financing its Covid-19 response work after President Donald Trump said the U.S. would withhold contributions. Trump said the U.S. will suspend funding to WHO while it reviews the agency's response to the Covid-19 pandemic. He said the administration will conduct a "thorough" investigation that should last 60 to 90 days. In the fiscal year 2019, the U.S. provided about $237 million as well as an additional $656 million in voluntary contributions to the agency, according to a WHO spokesperson, representing about 14.67% of its total budget. - Berkeley Lovelace Jr. | @BerkeleyJr | Healthy Returns Virtual Summit | May 12, 2020
The path forward for the health care industry at a time of unprecedented challenges
CNBC presents a virtual event featuring top health care CEOs, technologists and investors, exploring the ways the most innovative companies are addressing the coronavirus crisis, and the lasting effects the crisis will have on the industry.
From vaccines and treatments, to new tech and processes, to modeling the financial impacts and effects on legacy and upstart health care companies, Healthy Returns will feature some of the most influential voices in health care.
Led by CNBC's anchors and reporters, Healthy Returns will hone in on the groundbreaking ideas that will help mitigate the global pandemic, and will transform the health care industry for years to come. | |
Post a Comment